Arcus Biosciences Inc (RCUS)
Gross profit margin
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross profit (ttm) | US$ in thousands | 112,000 | 116,000 | 100,000 | 92,000 | -5,000 | -19 | 5,568 | 5,491 | 5,065 | 331,027 | 316,558 | 315,981 | 323,958 | 3,502 | 63,737 | 53,709 | 47,058 | 47,321 | -12,840 | -8,119 |
| Revenue (ttm) | US$ in thousands | 258,000 | 263,000 | 247,000 | 237,000 | 117,000 | 119,355 | 121,236 | 118,995 | 112,000 | 433,144 | 408,724 | 399,137 | 398,304 | 53,292 | 108,361 | 92,939 | 77,517 | 77,780 | 15,000 | 15,000 |
| Gross profit margin | 43.41% | 44.11% | 40.49% | 38.82% | -4.27% | -0.02% | 4.59% | 4.61% | 4.52% | 76.42% | 77.45% | 79.17% | 81.33% | 6.57% | 58.82% | 57.79% | 60.71% | 60.84% | -85.60% | -54.13% |
December 31, 2024 calculation
Gross profit margin = Gross profit (ttm) ÷ Revenue (ttm)
= $112,000K ÷ $258,000K
= 43.41%
The gross profit margin of Arcus Biosciences Inc has shown significant fluctuations over the period analyzed. Starting from negative margins in early 2020, the company gradually improved its gross profit margin to reach a peak of over 80% in late 2021. However, the margin declined sharply by the end of 2022 and continued to fluctuate around low single digits until mid-2023 when it briefly turned negative. Subsequently, the gross profit margin saw a notable rebound, reaching above 40% by the end of 2024. Overall, the company experienced a mix of challenges and improvements in its ability to generate profits from its core operations over the period under consideration.
Peer comparison
Dec 31, 2024